Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pain × Amantadine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Pain 1 Hyperalgesia 1

Interventions

pegfilgrastim 1 Zoledronic Acid 1 Samarium-153 1 Samarium 1 Radiotherapy 1 Prednisone 1 Lidocaine 1 Ketamine 1 Genistein 1 Filgrastim 1 Fentanyl 1 Extracorporeal Shockwave Therapy 1 Docetaxel 1 D-methadone 1 Azacitidine 1 Antibodies, Monoclonal 1 Amantadine 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00188383 2006-03-14

Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy

University Health Network, Toronto

Phase 1/2 Unknown

Hyperalgesia, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡